Sascha Kuerti
Hamburg, HH 20246, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer.
Journal: Journal of cancer research and clinical oncology
Published: July 29, 2023
Pelvic lymphadenectomy in vulvar cancer and its impact on prognosis and outcome.
Journal: Archives of gynecology and obstetrics
Published: December 19, 2020
Course of cervical intraepithelial neoplasia diagnosed during pregnancy.
Journal: Archives of gynecology and obstetrics
Published: October 07, 2019
Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.
Journal: British journal of cancer
Published: February 28, 2019
Comparison of PapilloCheck and Linear Array to Detect and Differentiate Human Papillomaviruses in Cervical and Tonsillar Smears from Females with Cervical Intraepithelial Lesions.
Journal: European journal of microbiology & immunology
Published: July 10, 2018
Participation of elderly gynecological cancer patients in clinical trials.
Journal: Archives of gynecology and obstetrics
Published: April 28, 2018
Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.
Journal: Disease markers
Published: April 09, 2018
Superficially invasive stage IA vulvar squamous cell carcinoma-therapy and prognosis.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 06, 2018
VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients.
Journal: Oncotarget
Published: February 20, 2017
E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer.
Journal: British journal of cancer
Published: July 12, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026